Inovio Pharmaceuticals Inc. Stock Slides 5.8%, Underperforms Peers

Dow Jones
2025/11/08

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. slid 5.8% to $2.12 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.2% to 46,987.10 and the NASDAQ Composite Index falling 0.2% to 23,004.54.

This was the stock's fourth consecutive day of losses.

Inovio Pharmaceuticals Inc. closed 62.1% short of its 52-week high of $5.60, which the company reached on November 11th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.2% to $186.57, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. remained unchanged.

Trading volume totaled 1.7 million, compared to the 50-day average of 1.3 million.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

November 07, 2025 16:34 ET (21:34 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10